Anavex Life Sciences Corp (AVXL)

[powerwalker]

As to your comment:

Since the design calls for 16 men and 16 women, I tend to think they may be having less success with recruiting women trial participants. Most women I know would be trial adverse versus men.


Most of the enrollees are probably not making the decision themselves but loved ones and/or caretakers. If they were aware of those early results, they would be willing to enroll the Alzheimer's patient, regardless of gender.

It would be good to see a PR from AVXL as to whether the 32 person threshold has been achieved.